It has been 5 years since the launch of ‘Herceptin’… a targeted agent for stomach cancer will come out

It is expected that a new targeted agent will be launched since the launch of ‘Herceptin’ 5 years ago.

According to the industry concerned on the 28^th, Lilly Korea is following procedures to acquire permission of the advanced stomach cancer and gastroesophageal junction adenocarcinoma treatment ‘Cyramza (Ramucirumab)’ at the beginning of the next year.

Stomach cancer is a disease having the h...